Markets & Finance

Lehman Raises D&K Healthcare to 'Strong Buy'


Lehman Brothers upgraded D&K Healthcare (DKWD) to strong buy from buy.

Analyst Lawrence Marsh says his upgrade is based on continued expansion in the rate of growth, and is benefiting from additional capital and a broadening customer base. He sees opportunities to expand management ranks over the next few months, benefiting from further consolidation in the industry. He notes good margin expansion opportunities off a lower base vs. the industry average, leading to faster growth prospects vs. its larger peers. Finally Marsh says shares are off 15% from its recent high, despite better than expected second quarter results. He raised his $66 one-year target to $70.


Too Cool for Crisis Management
LIMITED-TIME OFFER SUBSCRIBE NOW

Sponsored Financial Commentaries

Sponsored Links

Buy a link now!

 
blog comments powered by Disqus